Connect with us

Health

Ask A Vaccine Specialist: What Does The Future of the mRNA Platform Hold? – The Motley Fool

Its use in a coronavirus vaccine is an exciting step forward, but mRNA technology is unlikely to solve all of our problems.

Published

on

post featured image

Recently authorized coronavirus vaccines from Moderna (NASDAQ:MRNA) and the Pfizer(NYSE:PFE)-BioNTech(NASDAQ:BNTX) team are the first messenger RNA (mRNA) vaccines ever to be commercialized. Dr. Bruce Gellin of the Sabin Vaccine Institute joined Corinne Cardina and Olivia Zitkus of Fool.com’s Healthcare and Cannabis Bureau on a Dec. 18 episode of Fool Live to talk about some of the possibilities of the mRNA platform in vaccine and drug development. 
Olivia Zitkus: As an expert on these vaccines,…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending